Author:
Figueroa Castro Carlos E.,Palen Louis,Johnson Carrie,Graham Mary Beth,Letzer David,Ledeboer Nathan,Buchan Blake,Block Timothy,Seliger Heather,Singh Siddhartha,Behrens Elizabeth,Huerta Susan,Munoz-Price L. Silvia
Abstract
AbstractIn 2018, the Clostridium difficile LabID event methodology changed so that hospitals doing 2-step tests, nucleic acid amplification test (NAAT) plus enzyme immunofluorescence assay (EIA), had their adjustment modified to EIA-based tests, and only positive final tests (eg, EIA) were counted in the numerator. We report the immediate impact of this methodological change at 3 Milwaukee hospitals.
Publisher
Cambridge University Press (CUP)
Subject
Infectious Diseases,Microbiology (medical),Epidemiology
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献